2026/0141 - Invitation to Submit Proposals Under Framework Agreement(s) 2023/0436 (Medicines for the Central Nervous System), 2023/0491 (Oncological and Immunomodulatory Medicines)

The tender 2026/0141 invites proposals for the supply of various medicinal products under multiple framework agreements. These include medicines for the central nervous system (2023/0436), oncological and immunomodulatory medicines (2023/0491), and other categories such as anti-infectious medicines, analgesics, and medications for endocrine diseases. The procurement aims to ensure a steady supply of essential medications to meet healthcare needs. Key requirements for bidders may include compliance with regulatory standards, quality assurance protocols, and the ability to deliver products within specified timelines. The tender is open to qualified suppliers who can demonstrate experience in pharmaceutical supply and adherence to safety and efficacy standards. This initiative is crucial for maintaining the healthcare system's capacity to treat various medical conditions effectively. Interested parties should prepare their proposals in accordance with the guidelines provided in the tender documentation. The location of delivery and specific quantities required will be detailed in the full tender documents. This procurement process underscores the commitment to enhancing public health through reliable access to necessary medications.

This is a supplies contract in the information and communication technology sector. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 4,872.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the information and communication technology sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.